Global and Japan Fetal Bovine Serum for Life Sciences Market Insights, Forecast to 2027

Fetal bovine serum (FBS) or fetal calf serum (spelled foetal in Commonwealth English) is the blood fraction remaining after the natural coagulation of blood, followed by centrifugation to remove any remaining red blood cells. Fetal bovine serum comes from the blood drawn from a bovine fetus via a closed system of collection at the slaughterhouse. Fetal bovine serum is the most widely used serum-supplement for the in vitro cell culture of eukaryotic cells. This is due to it having a very low level of antibodies and containing more growth factors, allowing for versatility in many different cell culture applications.

Market Analysis and Insights: Global and Japan Fetal Bovine Serum for Life Sciences Market
This report focuses on global and Japan Fetal Bovine Serum for Life Sciences market.
In 2020, the global Fetal Bovine Serum for Life Sciences market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In Japan the Fetal Bovine Serum for Life Sciences market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Fetal Bovine Serum for Life Sciences Scope and Market Size
Fetal Bovine Serum for Life Sciences market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Fetal Bovine Serum for Life Sciences market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For Japan market, this report focuses on the Fetal Bovine Serum for Life Sciences market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type
North America-sourced
South America-sourced
Australia-sourced
Others

Segment by Application
Scientific Research
Industrial Production

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Thermo Fisher
GE Healthcare
Merck
Moregate BioTech
Gemini
Atlanta Biologicals
Tissue Culture Biologicals
Bovogen
Biowest